Roncolato, F. T., Joly, F., O'Connell, R., Lanceley, A., Hilpert, F., Buizen, L., . . . Friedlander, M. (2017). Reducing Uncertainty: Predictors of Stopping Chemotherapy Early and Shortened Survival Time in Platinum Resistant/Refractory Ovarian Cancer—The GCIG Symptom Benefit Study. Oncologist.
シカゴスタイル引用形Roncolato, Felicia T., et al. "Reducing Uncertainty: Predictors of Stopping Chemotherapy Early and Shortened Survival Time in Platinum Resistant/Refractory Ovarian Cancer—The GCIG Symptom Benefit Study." Oncologist 2017.
MLA引用形式Roncolato, Felicia T., et al. "Reducing Uncertainty: Predictors of Stopping Chemotherapy Early and Shortened Survival Time in Platinum Resistant/Refractory Ovarian Cancer—The GCIG Symptom Benefit Study." Oncologist 2017.